CAVDCollaboration for AIDS Vaccine Discovery (est. 2006)
CAVDCongenital Absence of the Vas Deferens
CAVDCustom Audio Video Distribution (various locations)
CAVDCanadian Academy of Veterinary Dermatology
CAVDCardiac Allograft Vascular Disease
CAVDClub Auto Verte Dunkerquois (French: Green Auto Club Dunkirk; Dunkirk, France)
CAVDComplete Atrio-Ventricular Canal Defect (cardiology)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
"For a long time, people thought CAVD was just the valvular equivalent of atherosclerosis," says Kristyn Masters, a professor of biomedical engineering at UW-Madison.
No study has tested whether there may be methodology-based differences in discriminating risk of CAVD. Further complicating Lp(a)-related risk assessment, race/ethnicity is a recognized determinant of Lp(a) concentrations, and black individuals are known to have 2- to 3-fold greater Lp(a) concentrations compared with whites and Hispanics (21-23).
In this study, our results demonstrated that Boxer dogs affected by CAVD have autonomic changes reflected by reduction of HRV parameters, and this reduction is not a consequence of the number or severity of ventricular arrhythmias.
While CAVD was originally thought to be a degenerative process with passive deposition of calcium phosphate in the valve occurring with age, it now appears to be a complex and actively regulated progress mediated by inflammation, cell apoptosis, lipid deposition, renin-angiotensin system activation, extracellular matrix remodeling, and bone formation [4-6].
Thus, early lesions of CAVD have some similarities with the atherosclerotic process (lipid accumulation, inflammatory infiltrate, and interruption of the basement membrane) and some differences (presence of early calcification and reduced number of smooth muscle cells).
A pDNA prime/poxvirus boost vaccine approach has been developed since 1998 by the EuroVacc programme and is currently the focus of the CAVD's Poxvirus T-cell Vaccine Discovery Consortium.
The permit also allows the conversion through the CAVD of ASR, and similar manmade wastes of plastic, carpet, etc.
The first is the creation of public-private partnerships (PPPs) that capitalize on the strengths of the public and private sectors such as the International AIDS Vaccine Initiative (IAVI) and the Global Aids Vaccine Alliance launched in 2000 (GAVI); the second is the global connection of researchers, government agencies and international organizations under the Global HIV/AIDS Vaccine Enterprise (GHAVE) with an aim to coordinating research, knowledge sharing and capacity building; and the third is the infusion of funding spearheaded by philanthropic partners including the Bill & Melinda Gates Foundation (the Gates Foundation) and the creation of PPPs such as the United States' Collaboration for AIDS Vaccine Discovery (CAVD).
Under the agreement, EarthFirst will be paid a $700,000 onetime licensing fee by Midwest Transport, which has been granted the exclusive fight to market EarthFirst's proprietary and patent-pending catalytic activated vacuum distillation (CAVD) technology in Ireland and the U.K.
However, several studies have shown that, in addition to age, calcific aortic valve disease (CAVD) is related to the presence of cardiovascular risk factors such as male sex, arterial hypertension, diabetes mellitus, dyslipidemia, and smoking, sharing many similarities with the process that regulates atherosclerosis [1-8].